Skip to main content
Caplight Logo









Numan

Numan

Private
LondonHealthcare & Life Scienceshttps://www.numan.com/

Last Round

Debt

Jul 16, 2025

Est. Valuation

$207.12M

Total Funding Raised

$100M

Momentum

Top 50%

of companies Caplight tracks

Company Overview

Numan is a digital health company that provides a platform for online consultations, prescription medications, and personalized treatments for various health conditions.

Sector

Healthcare & Life Sciences

Verticals

Telemedicine, Subscription Commerce, D2C Brands, Medical AI, Patient Engagement

Business Model

B2C

Customer Profile

Subscription SaaS, Services & Consulting

AI Layer

Application

Keywords

telehealth platformweight managementGLP-1 medicationmen's healthsubscription healthcaredirect-to-consumerD2Conline pharmacyerectile dysfunction treatmenthair loss treatmentwomen's healthfemtechonline consultationsdiagnostic blood testspreventive healthcareAI health coach

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Numan Comparables

Compare Numan with similar companies based on industry and business-model similarity.

Numan comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Voy
86%
Hims & Hers Health, Inc.
80%
Walgreens Boots Alliance
74%

Numan Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
DebtJul 16, 2025
DebtFeb 7, 2022
Series BSep 13, 2021
Series AOct 13, 2020

Numan Investors

Notable investors and investment history

Numan investors
InvestorRounds
Kreos CapitalDebt
White Star CapitalDebt, Series B
Novator PartnersDebt, Series B, Series A
Colle CapitalSeries B, Series A
Kreos CapitalDebt
VNV GlobalSeries B, Series A
Hanwha Asset ManagementSeries B

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jun 30, 2026

    Collaboration to design a behavioral intervention for obesity patients.

  • Feb 3, 2026

    Leveraging Intercom's AI tools for customer care operations.

Numan Filings

Explore SEC and related filing metadata, where available.

Numan filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Numan's valuation, stock price, and market status.

Is Numan a public or private company?

Numan is a private company.

What is the current stock price of Numan?

Numan is a private company with no public stock price. No recent secondary market data is available.

How much is Numan worth (valuation)?

Numan's valuation is estimated at $207.1M based on funding round data.

Can I buy Numan stock?

Numan shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Numan's last funding round?

Numan's most recent funding round was Series B on August 18, 2021.

Who are the main investors in Numan?

Key investors in Numan include White Star Capital, Novator Partners, Hellenic Development Bank of Investments, Big Pi Ventures, NaMa Capital.

Will Numan IPO soon?

No public IPO plans have been announced for Numan.

How can I track Numan secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Numan's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersLondon
Employee Range224
Year Founded2018
Last FundingJul 16, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?